Qube Research & Technologies (QRT)
CRL icon

Qube Research & Technologies (QRT)’s Charles River Laboratories CRL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Buy
+15,870
New +$2.83M ﹤0.01% 1797
2026
Q1 		– Sell
-5,797
Closed -$1.16M – 3614
2025
Q4 		$1.16M Buy
+5,797
New +$1.05M ﹤0.01% 2495
2025
Q1 		– Sell
-8,458
Closed -$1.56M – 3541
2024
Q4 		$1.56M Sell
8,458
-10,480
-55% -$2.02M ﹤0.01% 1980
2024
Q3 		$3.73M Sell
18,938
-52,051
-73% -$10.8M 0.01% 1527
2024
Q2 		$14.7M Buy
70,989
+65,649
+1,229% +$14.9M 0.02% 755
2024
Q1 		$1.45M Sell
5,340
-118
-2% -$28.2K ﹤0.01% 1930
2023
Q4 		$1.29M Buy
5,458
+3,793
+228% +$746K ﹤0.01% 1773
2023
Q3 		$326K Buy
+1,665
New +$342K ﹤0.01% 2210
2023
Q2 		– Sell
-25,237
Closed -$5.09M – 2481
2023
Q1 		$5.09M Buy
25,237
+16,091
+176% +$3.65M 0.02% 665
2022
Q4 		$1.99M Buy
+9,146
New +$2M 0.01% 949
2022
Q3 		– Sell
-83,092
Closed -$17.8M – 2571
2022
Q2 		$17.8M Buy
83,092
+9,388
+13% +$2.29M 0.13% 197
2022
Q1 		$20.9M Buy
73,704
+31,447
+74% +$9.7M 0.18% 143
2021
Q4 		$15.9M Buy
+42,257
New +$16.4M 0.12% 203
2021
Q2 		– Sell
-12,707
Closed -$3.68M – 2344
2021
Q1 		$3.68M Sell
12,707
-14,185
-53% -$3.94M 0.06% 437
2020
Q4 		$6.72M Buy
26,892
+3,264
+14% +$777K 0.1% 240
2020
Q3 		$5.35M Sell
23,628
-35,641
-60% -$7.4M 0.08% 337
2020
Q2 		$10.3M Buy
+59,269
New +$9.46M 0.15% 157
2019
Q3 		– Sell
-2,242
Closed -$318K – 287
2019
Q2 		$318K Buy
+2,242
New +$304K 0.08% 251
2018
Q4 		– Sell
-1,598
Closed -$215K – 425
2018
Q3 		$215K Buy
1,598
+1,115
+231% +$138K 0.03% 479
2018
Q2 		$54K Buy
+483
New +$52.2K 0.03% 489

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Charles River Laboratories (CRL) in Q2 2026: 15,870 shares worth $3.6M. The stake represents ﹤0.01% of the portfolio and ranks #1797 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CRL as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in CRL in Q2 2018 and has held it in 20 quarters since. The position peaked at $20.9M in Q1 2022. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Qube Research & Technologies (QRT) held 15,870 shares of Charles River Laboratories worth $3.6M as of Q2 2026.
  • Charles River Laboratories was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1797 holding.
  • Qube Research & Technologies (QRT) first reported a position in Charles River Laboratories in Q2 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Charles River Laboratories position peaked at $20.9M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.